{
    "organizations": [],
    "uuid": "b608c9d1464fb2e05d703531cc5aec509935847b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-obalon-therapeutics-q4-loss-per-sh/brief-obalon-therapeutics-q4-loss-per-share-0-60-idUSASB0C8TU",
    "ord_in_thread": 0,
    "title": "BRIEF-Obalon Therapeutics Q4 Loss Per Share $0.60",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5, 2018 / 8:06 PM / Updated 13 minutes ago BRIEF-Obalon Therapeutics Q4 Loss Per Share $0.60 Reuters Staff March 5 (Reuters) - Obalon Therapeutics Inc: * OBALON ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 REVENUE $3.7 MILLION VERSUS $800,000 * Q4 LOSS PER SHARE $0.60 Source text for Eikon: Further company coverage:",
    "published": "2018-03-05T22:03:00.000+02:00",
    "crawled": "2018-03-05T22:29:59.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "obalon",
        "therapeutic",
        "inc",
        "obalon",
        "announces",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "revenue",
        "million",
        "versus",
        "q4",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}